ABSTRACT
Strongyloidiasis is a soil-borne disease caused by nematodes of the genus Strongyloides. The species most relevant to human health is S. stercoralis. The infection can persist for life if left untreated and occurs in various clinical forms, from asymptomatic to death. It mainly affects tropical and subtropical regions, with an estimated 370 million people affected worldwide, including Mexico. The life cycle of this parasite is complex, with free-living and parasitic stages. Infective filariform larvae penetrate intact skin, reach the lungs and are swallowed, developing in the intestine. Diagnosis is challenging and is based on the detection of larvae in biological samples, as well as serological and molecular tests. The main treatment is ivermectin, effective against adult forms, but multiple rounds may be necessary due to the autoinfectious cycle. Immunocompromised people are more susceptible to severe and disseminated infections. The lack of awareness and resources in endemic areas makes timely diagnosis and treatment difficult. Strongyloidiasis is a neglected disease, receiving less attention and funding for research and treatment development. To address it, efforts are required in education, improvement of the health infrastructure, research and prevention strategies.

ABSTRACT
Scabies is a contagious skin infestation caused by Sarcoptes scabiei var. hominis. Human contamination occurs mainly through prolonged skin-to-skin contact with an infected person. The diagnosis of human scabies in case of co-morbidity with another chronic skin disease could be a real challenge. Here, we report an unusual and rare case of co-morbidity of crusted scabies with systemic lupus erythematosus in resource-limited setting treated successfully with a combination of medical treatments with lifestyle and dietary measures. This case also showed the diagnostic and management challenges in a setting where the health system presents some weaknesses.

ABSTRACT
Fungal surgical site infections (SSIs) trend to increase in the recent decades. This study aimed at estimating the prevalence of fungal SSIs, and the time of occurrence of fungal SSIs at the Sourô Sanou University Hospital (SSUHC) in Burkina Faso. This study was carried out in two departments of the SSUHC. Samples of postoperative purulent secretions were collected from June to December 2019. Purulent secretions swabs at the surgical site were aseptically collected using sterile cotton swabs. Standard mycology, CHROMagar, agglutination latex test and immunological test were used to identify the different Candida species. A total of 39 postoperative patients were included in the study. The median age was 27 years and the majority of patients were women (74.4%). The probability of isolating fungal agents from the surgical site was 2.6% three days after surgery. This probability was 14.4% and 49.5% at one week and 12 days after the surgical intervention, respectively. A total of 8 (20.51%) fungal species, all belonging to the genus Candida were identified in the study. These species were Candida albicans (3), Nakaseomyces glabrata (2), Candida tropicalis (2) and Pichia kudriavzevii (1). This study showed that Candida spp. could be the cause of the occurrence of SSIs at the SSUHC in Burkina Faso. So, physician must integrate the fungal causes in the management of SSIs.